|
⚲
|
| Keyboard |
| Nicholson C David
✚
|
|
|---|---|
| CIK # | 0001674650, 0001636168 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001636168] | |
| 4 | [0001636168] | |
| 3 | [0001674650] | |
| 4 | [0001674650] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nicholson C David | |
| Adverum Biotechnologies Inc | |
| Actinium Pharmaceuticals Inc | |
| Nicholson C David | |
| Allergan PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 10,450 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 8,000 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Disposed to issuer | 10,520 | ||
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 10,450 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 72,156 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 2,500 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 2,500 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 8,333 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 8,333 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 18,351 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 70,311 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 2,500 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2024-06-17 | Grant | 10,520 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2023-12-28 | Grant | 70,311 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2023-11-03 | Grant | 80,000 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2022-07-01 | Grant | 72,156 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2021-09-01 | Grant | 18,351 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2020-08-12 | Grant | 8,333 | $0.00 | |
|
Allergan PLC AGN
Ordinary Shares, par value $0.0001
|
2020-05-08 | Disposed to issuer | 9,999 | $0.00 | |
|
Allergan PLC AGN
Restricted Stock Units
|
2020-05-08 | Disposed to issuer | 25,201 | $0.00 | |
| showing 20 of 38 most recent transactions | |||||